Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Mar 2022 for Arena Pharmaceuticals INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Katharine Knobil: trading record in brief
Katharine Knobil, listed as board member, appears in our data through filings on Arena Pharmaceuticals Inc shares, published by SEC (Form 4). Over a trading history stretching from 12 June 2020 to 11 March 2022, the count stands at 5 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 11 March 2022, the filings show a transaction in Arena Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Katharine Knobil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,939 sharesCommon StockSEC:0001628280-22-005914:0
3,067 shares0Common StockSEC:0001628280-21-012285:0
2 of 2 declarations
